About gemcitabin e m
Antimetabolite chemotherapy medicine
Used for
- Treats pancreatic cancer
- Treats non-small-cell lung cancer
- Treats breast cancer
- Treats ovarian or bladder cancer
Usual adult dose
Dose varies by cancer and combination; commonly 1,000–1,250 mg/m² by intravenous infusion on scheduled treatment days.
Common side effects
- Low blood-cell counts
- Nausea and vomiting
- Fever or flu-like symptoms
- Rash or hair loss
Important warnings
- Can cause serious infection or bleeding from low blood counts
- May cause lung, liver, or kidney problems
- Rarely causes severe skin reactions or capillary leak syndrome
- Requires specialist monitoring and blood tests
Pregnancy
May harm an unborn baby. Avoid during pregnancy; effective contraception is recommended during treatment.
Breastfeeding
Breastfeeding is not recommended during treatment and for at least one week after the final dose.
Interactions
- Radiotherapy may increase tissue damage or blood disorders
- Live vaccines may cause serious infection during treatment
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.